Companion Animals

Companion Dog Cancer Immunotherapy Advances

Emerging cancer immunotherapy options for dogs and the welfare benefits of less toxic treatment approaches.

Key Facts

Cancer is the leading cause of death in dogs over ten years of age
Immunotherapy approaches including cancer vaccines and checkpoint inhibitors are in veterinary trials
Less toxic than traditional chemotherapy, immunotherapy improves quality of life during treatment
Canine cancer research benefits from and contributes to human oncology advances
Early detection through screening programs improves treatment outcomes significantly

Welfare Considerations

Traditional cancer chemotherapy often imposes significant welfare costs through nausea, immunosuppression, and reduced quality of life. Immunotherapy approaches that harness the immune system offer the prospect of better welfare during treatment while maintaining or improving efficacy.

What You Can Do

Enroll age-appropriate dogs in cancer screening programs where available
Ask your veterinary oncologist about clinical trials of immunotherapy treatments
Support veterinary cancer research that improves both treatment outcomes and quality of life